Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CABOZANTINIB S-MALATE Cause Covid-19? 248 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 248 reports of Covid-19 have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 0.6% of all adverse event reports for CABOZANTINIB S-MALATE.

248
Reports of Covid-19 with CABOZANTINIB S-MALATE
0.6%
of all CABOZANTINIB S-MALATE reports
19
Deaths
68
Hospitalizations

How Dangerous Is Covid-19 From CABOZANTINIB S-MALATE?

Of the 248 reports, 19 (7.7%) resulted in death, 68 (27.4%) required hospitalization, and 4 (1.6%) were considered life-threatening.

Is Covid-19 Listed in the Official Label?

Yes, Covid-19 is listed as a known adverse reaction in the official FDA drug label for CABOZANTINIB S-MALATE.

What Other Side Effects Does CABOZANTINIB S-MALATE Cause?

Diarrhoea (8,282) Fatigue (6,819) Off label use (5,245) Nausea (4,341) Decreased appetite (4,076) Blood pressure increased (2,939) Malignant neoplasm progression (2,718) Palmar-plantar erythrodysaesthesia syndrome (2,706) Weight decreased (2,657) Stomatitis (2,560)

What Other Drugs Cause Covid-19?

NIRMATRELVIR\RITONAVIR (22,066) OCRELIZUMAB (11,454) ADALIMUMAB (9,138) DUPILUMAB (6,986) RITUXIMAB (6,301) LENALIDOMIDE (6,223) TOFACITINIB (4,926) SECUKINUMAB (3,871) INFLIXIMAB (3,698) TACROLIMUS (3,201)

Which CABOZANTINIB S-MALATE Alternatives Have Lower Covid-19 Risk?

CABOZANTINIB S-MALATE vs CAFFEINE CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL CABOZANTINIB S-MALATE vs CALCIFEDIOL CABOZANTINIB S-MALATE vs CALCIPOTRIENE

Related Pages

CABOZANTINIB S-MALATE Full Profile All Covid-19 Reports All Drugs Causing Covid-19 CABOZANTINIB S-MALATE Demographics